Darunavir

[(1R,5S,6R)-2,8-dioxabicyclo[3.3.0]oct-6-yl] N-[(2S,3R)-4- [(4-aminophenyl)sulfonyl- (2-methylpropyl)amino]-3-hydroxy-1-phenyl- butan-2-yl]

Purity / Analysis Method	≥98% (HPLC)
Molecular Formula / Molecular Weight	C₂₇H₃₇N₃O₇S = 547.66
Form	Powder
CAS RN	206361-99-1

Unit	Price
100 mg	7500
250 mg	11500
1 g	16500

Description
Additional information

Appearance	white to beige powder
Purity / Analysis Method	≥98% (HPLC)
storage temperature	−20°C

Note	• Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. • The contents of the specifications are subject to change without advance notice. The specification values displayed here are the most up to date values. There may be cases where the product labels display different specification; however, the product quality still meets the latest specification.

Note

• Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia.
• The contents of the specifications are subject to change without advance notice. The specification values displayed here are the most up to date values. There may be cases where the product labels display different specification; however, the product quality still meets the latest specification.

Researching Relationships

Darunavir

For API and Polymers

Useful Links

Important Links

Location

Darunavir

Related products

Amlodipine Besylate

Amikacin sulfate

Alendronate Sodium (Alendronic Acid Mono)

Fluorouracil (5-FU)

For API and Polymers

Useful Links

Important Links

Location